What is she best known for?
The fields of study she is best known for:
- Internal medicine
- Cancer
- Disease
Her scientific interests lie mostly in Internal medicine, Surgery, Oncology, Cancer and Frontotemporal lobar degeneration.
Internal medicine connects with themes related to Cardiology in her study.
The various areas that she examines in her Surgery study include Sigmoidoscopy, Quality-adjusted life year and Cost-effectiveness analysis.
Her Oncology study integrates concerns from other disciplines, such as Bone transplantation, Cancer prevention, Cohort study and Transplantation.
Her Cancer research is multidisciplinary, relying on both Lymph node, Gynecology, Lymph and Mass screening.
Her studies deal with areas such as Genetics and Amyotrophic lateral sclerosis as well as Frontotemporal lobar degeneration.
Her most cited work include:
- Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine (1049 citations)
- Meta-analysis: Diagnostic Accuracy of Anti–Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor for Rheumatoid Arthritis (593 citations)
- Cost-effectiveness of screening for colorectal cancer in the general population. (580 citations)
What are the main themes of her work throughout her whole career to date?
The scientist’s investigation covers issues in Internal medicine, Surgery, Oncology, Cost-effectiveness analysis and Colorectal cancer.
Her study brings together the fields of Cardiology and Internal medicine.
As a member of one scientific family, she mostly works in the field of Surgery, focusing on Quality-adjusted life year and, on occasion, Pediatrics.
Within one scientific family, she focuses on topics pertaining to Disease under Oncology, and may sometimes address concerns connected to Intensive care medicine.
Her Colorectal cancer research is multidisciplinary, incorporating perspectives in Radiology and Mass screening.
In her work, Cervical cancer is strongly intertwined with Gynecology, which is a subfield of Breast cancer.
She most often published in these fields:
- Internal medicine (32.14%)
- Surgery (18.68%)
- Oncology (15.93%)
What were the highlights of her more recent work (between 2015-2021)?
- Cost-effectiveness analysis (12.09%)
- Internal medicine (32.14%)
- Colorectal cancer (12.09%)
In recent papers she was focusing on the following fields of study:
Karen M. Kuntz mostly deals with Cost-effectiveness analysis, Internal medicine, Colorectal cancer, Cohort and Oncology.
Her study in Cost-effectiveness analysis is interdisciplinary in nature, drawing from both Psychological intervention, Operations management, Risk analysis, Prostate cancer and Operations research.
Karen M. Kuntz has researched Internal medicine in several fields, including Gastroenterology and Physical therapy.
Her Cohort research includes themes of Colonoscopy, Quality-adjusted life year, Radiology and Emergency medicine.
Her research on Oncology also deals with topics like
- Androgen deprivation therapy, Breast cancer and Adjuvant most often made with reference to Chemotherapy,
- Biomarker which connect with Pathology, Cognitive impairment, Cerebrospinal fluid and Prostate.
Her study explores the link between Surgery and topics such as Cohort study that cross with problems in Pediatrics.
Between 2015 and 2021, her most popular works were:
- Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine (1049 citations)
- Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force (239 citations)
- Societal and Family Lifetime Cost of Dementia: Implications for Policy (44 citations)
In her most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
Her primary areas of investigation include Cost-effectiveness analysis, Cohort, Quality-adjusted life year, Dementia and Cognition.
Her Cost-effectiveness analysis study combines topics in areas such as Risk analysis, Prostate cancer and Operations research.
To a larger extent, Karen M. Kuntz studies Internal medicine with the aim of understanding Prostate cancer.
The Adverse effect research Karen M. Kuntz does as part of her general Internal medicine study is frequently linked to other disciplines of science, such as Armodafinil, therefore creating a link between diverse domains of science.
Her Cohort research includes elements of Colonoscopy, Sigmoidoscopy and Emergency medicine.
Her work carried out in the field of Sigmoidoscopy brings together such families of science as Surgery, Fecal occult blood, Pediatrics and Cohort study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
